IL22 and infectious otitis media: Moreover, a study has shown, by using a colitis-associated cancer (CAC) model (AOM-DSS), that a myeloid cell-specific signaling protein CARD9 can regulate the IL-22 production by ILC3s during colonic inflammation, affecting the inflammation-associated carcinogenesis further supporting the pro-tumoral hypothesis.